|
Fair Value Measurement (Details) (USD $)
|
3 Months Ended | |
|---|---|---|
|
Oct. 06, 2013
|
Dec. 30, 2012
|
|
| Fair Value Measurement | ||
| Cash realized from liquidation of insurance policies | $ 3,300,000 | |
| Cash surrender value | 2,900,000 | |
| Liabilities: | ||
| Deferred compensation plan | 3,000,000 | |
|
Recurring | Fair value
|
||
| Assets: | ||
| Investments in rabbi trust | 3,418,000 | |
| Life insurance policies | 2,920,000 | |
| Total assets measured at fair value | 3,418,000 | 2,920,000 |
| Liabilities: | ||
| Derivative - interest rate swap | 743,000 | 1,216,000 |
| Deferred compensation plan | 2,974,000 | |
| Total liabilities measured at fair value | 743,000 | 4,190,000 |
|
Recurring | Level 1
|
||
| Assets: | ||
| Investments in rabbi trust | 3,418,000 | |
| Total assets measured at fair value | 3,418,000 | |
|
Recurring | Level 2
|
||
| Assets: | ||
| Life insurance policies | 2,920,000 | |
| Total assets measured at fair value | 2,920,000 | |
| Liabilities: | ||
| Derivative - interest rate swap | 743,000 | 1,216,000 |
| Deferred compensation plan | 2,974,000 | |
| Total liabilities measured at fair value | $ 743,000 | $ 4,190,000 |
| X | ||||||||||
|
- Definition
This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This element represents the portion of a balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount that could be realized under a life insurance contract or contracts owned by the Company as of the date of the statement of financial position. Such Company-owned life insurance policies are commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer). No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents investment securities as of the balance sheet date which may include marketable securities, derivative financial instruments, and investments accounted for under the equity method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the aggregate of the liabilities reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The cash inflow associated with the sale of insurance policy investment assets during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|